Excellence in nanoparticle analysis

Our ultra-sensitive patented technologies have unique capabilities for studying the processes involved for next generation medicines to reach the interior of our cells. Our waveguide technology provide unique ways to observe e.g. structural changes and affinity to better understand how we can affect and fight hostile nanoparticles.

Impact: Next generation drug delivery vehicles and diagnostic applications

CEO: Nils Löfgren

GUV Contact: Jesper Dahlberg